TABLE 1. Some Representative Results from the Screening of
Reaction Conditions for the N-Arylation of Imidazole with
4-Bromoanisolea
Simple Copper Salt-Catalyzed N-Arylation of
Nitrogen-Containing Heterocycles with Aryl and
Heteroaryl Halides
Liangbo Zhu, Peng Guo, Gaocan Li, Jingbo Lan,
Rugang Xie, and Jingsong You*
imidazole
(mmol)
yieldb
(%)
entry
solvent
base
Key Laboratory of Green Chemistry and Technology of Ministry
of Education, College of Chemistry, and State Key Laboratory
of Biotherapy, West China Hospital, West China Medical
School, Sichuan UniVersity, 29 Wangjiang Road,
Chengdu 610064, PR China
1
2
3
4
5
6
7
8
9
1.6
1.4
1.2
1.0
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
DMF
DMF
DMF
DMF
Cs2CO3
Cs2CO3
Cs2CO3
Cs2CO3
Cs2CO3
Cs2CO3
Cs2CO3
Cs2CO3
KOH
86
89
78
45
72
71
c
74
48
44
63
44
none
DMSO
toluene
n-butanol
DMF
DMF
DMF
ReceiVed June 12, 2007
10
11
12
NaOH
K2CO3
K3PO4
DMF
a Reaction conditions: 1a (1.0 mmol), base (2.0 mmol) in the presence
of CuI (0.2 mmol) in 2.0 mL of solvent at 120 °C under N2 atmosphere.
b Isolated yields (average of two runs). c Little coupling product was
determined.
These well-known reactions, however, generally suffer from
several limitations: (i) high reaction temperatures (often 150 °C
or as high as 200 °C), (ii) the use of stoichiometric amounts of
copper reagents, (iii) moderate yields, and (iv) poor substrate
generality. It is therefore not surprising that great efforts have
been directed toward the development of a mild as well as highly
efficient method for constructing N-arylazole units.4,5 Recently,
Buchwald6 and Taillefer7 have discovered and developed the
copper catalytic path for N-arylation of nitrogen-containing
heterocycles with aryl halides in the presence of N- and O-based
ligands under relatively mild conditions, which has led to a
resurgence of interest in Ullmann-type coupling reactions due
to the economic attractiveness of copper.8 Quite recently, our
laboratory has also presented highly efficient CuI-catalyzed
N-arylation procedures for N-containing heterocycles with aryl
and heteroaryl bromides or chlorides through the use of (S)-
pyrrolidinylmethylimidazole ligands.9
Relatively mild and highly efficient CuI-catalyzed N-
arylation procedures for nitrogen-containing heterocycles
(e.g., imidazoles, benzimidazoles, pyrroles, pyrazoles, in-
doles, triazoles, etc.) with aryl and heteroaryl halides have
been developed. The protocols can be performed easily and
tolerate a number of functional groups, such as ester, nitrile,
nitro, ketone, free hydroxyl, and free primary amine on the
aryl halide.
N-Arylimidazoles, N-arylpyrroles, N-arylpyrazoles, N-arylin-
doles, and N-aryltriazoles have received great attention in a
variety of fields throughout the chemical, pharmaceutical, and
material sciences.1 Traditionally, these N-arylazoles have been
synthesized via SNAr (nucleophilic aromatic substitution) of
N-containing heterocycles with electron-deficient aryl halides2
or via the classical Ullmann-type coupling with aryl halides.3
Recently, we have developed the CuCl-catalyzed N-arylation
of imidazole with arylboronic acids in protic solvents in the
(4) Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. 2003, 42, 5400.
(5) Several Pd-catalyzed C-N formation methods have been discovered,
which, upon using some relatively expensive and air-sensitive sterically
hindered phosphine ligands, allowed cross-couplings of aryl halides with
N-H heterocycles to proceed under mild conditions. (a) Anderson, K. W.;
Tundel, R. E.; Ikawa, T.; Altman, R. A.; Buchwald, S. L. Angew. Chem.,
Int. Ed. 2006, 45, 6523. (b) Muci, A. R.; Buchwald, S. L. Top. Curr. Chem.
2002, 219, 131. (c) Yang, B. H.; Buchwald, S. L. J. Organomet. Chem.
1999, 576, 125. (d) Hartwig, J. F. Angew. Chem., Int. Ed. 1998, 37, 2046.
(e) Hartwig, J. F. Acc. Chem. Res. 1998, 31, 852. (f) Wolfe, J. P.; Wagan,
S.; Marcoux, J.-F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805. (g)
Jiang, L.; Buchwald, S. L. Palladium-Catalyzed Aromatic Carbon-Nitrogen
Bond Formation. In Metal-Catalyzed Cross-Coupling Reactions, 2nd ed.;
de Meijere, A., Diederich, F., Eds.; Wiley-VCH: Weinheim, Germany,
2004; p 699.
(6) (a) Antilla, J. C.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc.
2002, 124, 11684. (b) Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S.
L. J. Am. Chem. Soc. 2001, 123, 7727. (c) Antilla, J. C.; Baskin, J. M.;
Barder, T. E.; Buchwald, S. L. J. Org. Chem. 2004, 69, 5578.
(7) (a) Cristau, H. J.; Cellier, P. P.; Spindler, J. F.; Taillefer, M. Eur. J.
Org. Chem. 2004, 695. (b) Taillefer, M.; Cristau, H. J.; Cellier, P. P.;
Spindler, J. F. FR 0116547, 2001. (c) Cristau, H. J.; Cellier, P. P.; Spindler,
J. F.; Taillefer, M. Chem.sEur. J. 2004, 10, 5607.
(1) (a) Craig, P. N. In ComprehensiVe Medicinal Chemistry; Drayton,
C. J., Ed.; Pergamon Press: New York, 1991; Vol. 8. (b) Cozzi, P.;
Carganico, G.; Fusar, D.; Grossoni, M.; Menichincheri, M.; Pinciroli, V.;
Tonani, R.; Vaghi, F.; Salvati, P. J. Med. Chem. 1993, 36, 2964. (c) Negwer,
M. In Organic-Chemical Drugs and their Synonyms: An International
SurVey, 7th ed.; Akademie Verlag GmbH: Berlin, Germany, 1994. (d)
Kundu, N. G.; Mahanty, J. S.; Chowdhurry, C.; Dasgupta, S. K.; Das, B.;
Spears, C. P.; Balzarini, J.; De Clercq, E. Eur. J. Med. Chem. 1999, 34,
389. (e) Kunz, K.; Scholtz, U.; Ganzer, D. Synlett 2003, 15, 2428. (f)
Herrmann, W. A. Angew. Chem., Int. Ed. 2002, 41, 1290.
(2) (a) Bambal, R.; Haznlik, R. P. J. Org. Chem. 1994, 59, 729. (b)
Venuti, M. C.; Stephenson, R. A.; Alvarez, R.; Bruno, J. J.; Strosberg, A.
M. J. Med. Chem. 1988, 31, 2136. (c) Qiao, J. X.; Cheng, X.; Modi, D. P.;
Rossi, K. A.; Luettgen, J. M.; Knabb, R. M.; Jadhav, P. K.; Wexler, R. R.
Bioorg. Med. Chem. Lett. 2005, 15, 29. (d) Gu¨ngo¨r, T.; Fouquet, A.; Teulon,
J.-M.; Provost, D.; Cazes, M.; Cloarec, A. J. Med. Chem. 1992, 35, 4455.
Also see ref 4.
(3) (a) Jacobs, C.; Frotscher, M.; Dannhardt, G.; Hartmann, R. W. J.
Med. Chem. 2000, 43, 1841. (b) Fan, J.; Sun, W.; Okamura, T.; Tang, W.;
Ueyama, N. Inorg. Chem. 2003, 42, 3168. (c) Martinez, G. R.; Walker, K.
A. M.; Hirschfeld, D. R.; Bruno, J. J.; Yang, D. S.; Maloney, P. J. J. Med.
Chem. 1992, 35, 620. Also see refs 2b and 4.
10.1021/jo0712289 CCC: $37.00 © 2007 American Chemical Society
Published on Web 09/29/2007
J. Org. Chem. 2007, 72, 8535-8538
8535